Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02602262 · ClinicalTrials.gov registry record
Observational Study of HIV+ Deceased Donor Transplant for HIV+ Recipients
A clinical trial of HIV Infection, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 105
- Enrollment target
- 18
- Study locations
NCT02602262: Completed study of HIV Infection, sponsored by Johns Hopkins University.
NCT02602262 is a study of HIV Infection that has completed, run by Johns Hopkins University. The registered enrollment target is 105 participants, below the 241-participant average among 73 other HIV Infection trials with a reported enrollment target (56% lower). The trial reports 18 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02602262, a study of HIV Infection, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 105 participants
- Enrollment target
- 18
- Study locations
Study Summary
HIV-infected (HIV+) individuals who agree to accept and receive a solid organ transplant from an HIV+ deceased donor will be followed to determine the safety and efficacy of this practice. Some HIV+ individuals who receive a solid organ transplant from HIV-uninfected (HIV-) donors will also be followed.
Conditions Studied
Interventions
- OTHER HIV-infected deceased donor organ
Study Locations (18)
New York
- New York University School of Medicine - New York
- Icahn School of Medicine at Mount Sinai - New York
- Columbia University Medical Center - New York
- Weill Cornell Medical College - New York
Illinois
- Northwestern University - Chicago
- Rush University Medical Center - Chicago
- University of Illinois at Chicago - Chicago
Maryland
- University of Maryland, Institute of Human Virology - Baltimore
- Johns Hopkins University - Baltimore
Colorado
- University of Colorado Denver - Aurora
Connecticut
- Yale University School of Medicine - New Haven
District of Columbia
- Georgetown University Medical Center - Washington D.C.
Georgia
- Emory University - Atlanta
Indiana
- Indiana University - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2015-11 |
| Est. Completion | 2023-06-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02602262
The ClinicalTrials.gov registry entry for NCT02602262 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 241-participant average among 73 other HIV Infection trials with a reported enrollment target (56% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with HIV Infection appearing as the primary indexed condition, and to 1 intervention - of which HIV-infected deceased donor organ is the first listed.
NCT02602262 reports 18 study locations spanning 12 distinct geographic areas - top geographies include New York, Illinois, Maryland.
Frequently Asked Questions
What is clinical trial NCT02602262 about?
NCT02602262 is a clinical study titled "Observational Study of HIV+ Deceased Donor Transplant for HIV+ Recipients". HIV-infected (HIV+) individuals who agree to accept and receive a solid organ transplant from an HIV+ deceased donor will be followed to determine the safety and efficacy of this practice. Some HIV+ individuals who receive a solid organ transplant from HIV-uninfected (HIV-) donors will also be follo...
What is the current status of trial NCT02602262?
This trial is currently completed. The enrollment target is 105 participants. The study started on 2015-11. Estimated completion is 2023-06-16.
What conditions does trial NCT02602262 study?
This clinical trial studies the following conditions: HIV Infection.
What interventions are being tested in trial NCT02602262?
The interventions under investigation include: HIV-infected deceased donor organ (OTHER).
Who is sponsoring clinical trial NCT02602262?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02602262 being conducted?
This trial has 18 study locations across Colorado, Connecticut, District of Columbia, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
RECRUITING · Phase 2
-
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
RECRUITING · Phase 1
-
MAPS PrEP Van Study
RECRUITING · Phase 4
-
HIV+ Deceased Donor Heart Transplant Study for HIV+ Recipients
RECRUITING · NA
-
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
RECRUITING · NA
-
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
RECRUITING
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.